HealthDay on MSN3d
ASA: Mechanical Removal of Clot No Better Than Best Medical Treatment for Medium or Distal Vessel OcclusionEndovascular thrombectomy (EVT) does not lead to better outcomes at 90 days compared with usual care or best medical ...
Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...
Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...
New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.
The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...
China: A recent study published in the Journal of Stroke and Cerebrovascular Diseases has highlighted the potential of ...
Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse ...
In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback